Pure Global

Amphilimus (Sirolimus + Organic Acid) Eluting Coronary Stent - FDA Registration 7dde4b853abd384ec073308f82f84068

Access comprehensive regulatory information for Amphilimus (Sirolimus + Organic Acid) Eluting Coronary Stent in the Myanmar medical device market through Pure Global AI's free database. This medical device is registered under FDA ID 7dde4b853abd384ec073308f82f84068 and manufactured by CID S.p.A.. The device was registered on December 07, 2022.

This page provides complete registration details including manufacturer information, authorized representative details, and regulatory compliance data from the official Myanmar FDA medical device database. Pure Global AI offers free access to Myanmar's complete medical device registry.

Free Database
Powered by Pure Global AI
FDA Official Data
7dde4b853abd384ec073308f82f84068
Amphilimus (Sirolimus + Organic Acid) Eluting Coronary Stent
FDA ID: 7dde4b853abd384ec073308f82f84068
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Brand Name
CRE8
Registration Information
Analysis ID
7dde4b853abd384ec073308f82f84068
Registration Date
December 07, 2022
Manufacturer
Authorized Representative